FDA Inspection 1220683 — Mirum Pharmaceuticals, Inc.
The FDA completed an inspection of Mirum Pharmaceuticals, Inc. on October 3, 2023 in Foster City, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 3, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Foster City, CA (United States)
Additional Details
Sponsor, Contract Research Organization